1. Meta-analysis assessing cardiovascular outcomes with febuxostat versus allopurinol for patients with gout. (14th October 2021) Authors: Patoulias, D; Boulmpou, A; Tranidou, A; Nikolaidis, A; Papadopoulos, C E; Vassilikos, V; Bakatselos, S; Damianidis, G; Doumas, M Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Meta-analysis of cardiovascular outcome trials assessing the cardiovascular efficacy and safety of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus. (14th October 2021) Authors: Patoulias, D; Boulmpou, A; Teperikidis, E; Katsimardou, A; Siskos, F; Tranidou, A; Nikolaidis, A; Mouselimis, D; Doumas, M; Papadopoulos, C E; Vassilikos, V Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Risk of death with sodium-glucose co-transporter-2 inhibitors across the hallmark cardiovascular and renal outcome trials: an updated meta-analysis. (14th October 2021) Authors: Patoulias, D; Boulmpou, A; Tranidou, A; Nikolaidis, A; Mouselimis, D; Papadopoulos, C E; Vassilikos, V; Doumas, M Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Sodium-glucose co-transporter-2 inhibitors improve cardiovascular outcomes in heart failure with reduced ejection fraction regardless of ischemic etiology. (14th October 2021) Authors: Patoulias, D; Boulmpou, A; Tsavousoglou, C; Toumpourleka, M; Siskos, F; Nikolaidis, A; Papadopoulos, C.E; Vassilikos, V; Doumas, M Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗